Stochter
M
ME NEWS 24 Apr 2025, 06:55
Molina Healthcare Posts Solid Q1 2025 Results, Reaffirms Full-Year Guidance


Molina Healthcare reported strong financial results for the first quarter of 2025, underscoring effective cost management and solid premium growth. The company achieved GAAP earnings of $5.45 per diluted share and adjusted earnings of $6.08 per diluted share, both reflecting year-over-year growth.

Key Highlights:

Total revenue: $11.15 billion (+12% YoY)

Premium revenue: $10.63 billion (+12% YoY)

GAAP net income: $298 million (+5% YoY)

Adjusted net income: $333 million (+6% YoY)

Medical care ratio (MCR): 89.2% vs. 88.5% in Q1 2024

Adjusted G&A ratio: 6.8%, reflecting continued operating efficiency

Membership: 5.75 million (+25,000 YoY)

Segment MCRs:

Medicaid: 90.3%

Medicare: 88.3%

Marketplace: 81.7% (adjusted ~77.7% excluding risk reconciliation effects)

Capital & Liquidity:

Cash at parent company: $191 million

Share repurchase: $500 million (1.7 million shares) in Q1

Operating cash flow: $190 million

Guidance (2025, reaffirmed):

Premium revenue: ~$42 billion

GAAP EPS: ≥ $22.32

Adjusted EPS: ≥ $24.50 (+8% YoY)

New store embedded earnings: $8.65 per share (2026–2028 potential)

CEO Joseph Zubretsky stated that Molina is “executing well in a disciplined manner,” with solid momentum in both revenue and earnings. The company maintains its long-term target of 13–15% annual adjusted EPS growth.

Comments

No comments yet.